Teva receives FDA approval of WELTRUZA (olanzapine) for schizophrenia in adults

Teva Pharmaceuticals received FDA approval of WELTRUZA (olanzapine), an extended-release injectable suspension for the treatment of schizophrenia in adults.

Detected & updated continuously · Source: Nebula